Transplant Diagnostics Market Growth Trajectory Through 2024-2033

The Transplant Diagnostics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Transplant Diagnostics Market:
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

According to The Business Research Company’s Transplant Diagnostics Global Market Report 2024, The transplant diagnostics market size has grown rapidly in recent years. It will grow from $1.82 billion in 2023 to $2.01 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to development of hla typing, growth in organ transplantations, immunosuppressive therapy advancements, introduction of cross-matching techniques, regulatory standardization.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.57 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to patient-centric approaches, regulatory adaptations, rise in living donor transplants, personalized transplant medicine, growth in transplant procedures. Major trends in the forecast period include education and awareness programs, market expansion strategies, regulatory guidelines evolution, immunosuppressive therapy optimization, biomarker development.

Rising incidents of acute diseases are leading to an increase in organ failure rates, thus increasing the demand for transplant procedures driving the transplant diagnostics market. Organ transplant is a complex process and the success of the procedure depends on the acceptance of the donor’s organ by the recipient’s body system. To check whether the organ transplant can be successful, transplant diagnostic tests are performed. According to the United Network for Organ Sharing, a US-based non-private organization that manages organ transplantation in the US, in the year 2021, The U.S. saw a record-setting number of organ transplants. 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplantation procedures were performed in 2021. This high demand for diagnostic tests is driving the transplant diagnostics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2481&type=smp

The transplant diagnostics market covered in this report is segmented –

1) By Type: Reagent & Consumables, Instrument, Software & Services
2) By Transplant Type: Solid Organ, Stem Cell
3) By Organ: Kidney, Liver, Heart, Lung, Pancreas
4) By Technology: Non Molecular Assay, Molecular Assay
5) By End User: Hospitals and Transplant Centers, Research Laboratories & Transplant Centers, Commercial Service Providers

Major companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostics services to maximize their profits in the market. Advanced transplant diagnostic services refer to the use of novel and advanced diagnostic tools and technologies to improve the accuracy and efficiency of pre-transplant and post-transplant testing. For instance, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, an extensive collection of innovative diagnostics and support services created to increase access to lab tests for solid organ, human cell, and tissue transplants. It features a thorough selection of more than 170 specialized transplant and infectious disease tests, longitudinal trend analysis of test results in the doctor’s electronic medical record (EMR), and round-the-clock support services, including medical consultation to ensure appropriate test selection and result interpretation affecting care. The new services build on Quest’s previous offering in transplant testing with new capabilities. These capabilities include new patient-customized information packets to help educate patients on the process and help Quest’s phlebotomists fast-track testing for patients visiting one of Quest’s 2,100 patient service centers. Results for some tests can be obtained within 8–24 hours.

The transplant diagnostics market report table of contents includes:

1. Executive Summary
2.Transplant Diagnostics Market Characteristics
3.Transplant Diagnostics Market Trends And Strategies
4.Transplant Diagnostics Market analysis
5.Transplant Diagnostics Market Size And Growth
6.Transplant Diagnostics Segmentation
7.Transplant Diagnostics Regional And Country Analysis
.
.
.
27. Transplant Diagnostics Competitive Landscape And Company Profiles
28.Transplant Diagnostics Key Mergers And Acquisitions
29.Transplant Diagnostics Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• F. Hoffmann La-Roche AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Becton-Dickinson and Company
• Hologic Inc.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model